---
title: "Decision Portfolio"
date: 2026-01-20
description: "Decision systems, not achievements - evidence of how I approach high-stakes product decisions"
---

<div style="text-align: center; margin-bottom: 2rem;">
  <a href="/resume.pdf" download="Athan-Dial-Resume.pdf" style="display: inline-block; padding: 0.75rem 1.5rem; background-color: var(--accent); color: white; text-decoration: none; border-radius: 8px; font-weight: 500; transition: background-color 0.2s;">
    ðŸ“„ Download PDF Resume
  </a>
</div>

# Athan Dial, PhD

**PhD-trained in multi-omics analysis. Product-tested in drug discovery ML.**

I design decision systems for ambiguous, high-stakes problems. I combine research-grade evaluation rigor with product judgment to ship measurable outcomes. I communicate in decisions, metrics, and tradeoffsâ€”not activity.

---

## Decision Systems Portfolio

### System 1: Preventing Metric Theater in Drug Discovery ML

**Decision Context:** Data science teams were presenting accuracy metrics without reliability monitoring, creating false confidence in model predictions for multimillion-dollar compound selection decisions. Each compound decision represented $2M+ in development costs, but we lacked visibility into model performance degradation over time.

**My Decision:** I designed a combined evaluation framework (offline validation + online monitoring) instead of choosing between them. This required coordinating across ML, platform, and biology teams to establish baseline validation and production monitoring infrastructure.

**Outcome:** De-risked $2M+ in compound development by catching model degradation 3 months earlier than previous processes. The framework identified performance drift in two models before they influenced compound selection decisions. Established evaluation framework as standard for all discovery ML models.

**Key Tradeoff:** I sacrificed implementation speed (3 months vs. 2 weeks for offline-only) to gain defensibility and early warning signals. The infrastructure investment paid off across multiple models and use cases.

[Full Case Study â†’](/case-studies/preventing-metric-theater-drug-discovery-ml/)

---

### System 2: Reducing Pipeline Latency to Accelerate Decision Velocity

**Decision Context:** Analytics pipelines took 4-6 hours to run, blocking daily decision-making for 6+ discovery teams. Teams couldn't iterate on compound prioritization during meetings, forcing them to reconvene laterâ€”slowing R&D velocity and reducing confidence in data-driven decisions.

**My Decision:** I redesigned the data warehouse architecture using dbt + S3/Parquet with incremental models and materialized views. I prioritized latency reduction over feature completeness to unblock the decision-making bottleneck first.

**Outcome:** Reduced pipeline runtime from 4-6 hours to 20-30 minutes (85-90% reduction), enabling same-day iteration on compound prioritization. Reduced compute costs by ~$75k/year through architectural optimization. Analytics became the default path for nomination decisions across all discovery teams.

**Key Tradeoff:** I deferred some advanced analytics features to focus on infrastructure reliability and speed. Teams could make faster decisions with core metrics instead of waiting longer for comprehensive dashboards.

[Full Case Study â†’](/case-studies/reducing-pipeline-latency-decision-velocity/)

---

### System 3: PhD Research - Multi-Omics Pipeline Design Under Resource Constraints

**Decision Context:** During my PhD at McMaster University (2017-2022), I designed multi-omics analysis pipelines where the right evaluation approach wasn't obvious from existing literature. I had to decide how to allocate limited sequencing budget across validation experiments while maintaining statistical rigor.

**My Decision:** I developed evaluation frameworks from first principles, explicitly modeling the cost-benefit tradeoffs of different validation strategies. I prioritized experiments that maximized learning per dollar while maintaining sufficient statistical power.

**Outcome:** Successfully translated complex multi-omics data into actionable biological insights that informed experimental design. Published peer-reviewed research demonstrating the validity of the evaluation approach. Developed the "design decision systems under resource constraints" skillset that I now apply to product decisions.

**Key Tradeoff:** I chose statistical rigor over comprehensive coverageâ€”validating core hypotheses thoroughly rather than testing everything superficially. This approach prevented false confidence while staying within budget constraints.

---

## Current Role

**Data Research Lead | Montai Therapeutics | 2022-Present**

I lead decision systems design for drug discovery analytics, owning evaluation frameworks, data architecture, and stakeholder alignment. I partner with executives, scientists, and ML teams to turn ambiguous requirements into shipped outcomes.

**Key Contributions:**
- Scaled decision-support apps cutting cycle time by ~90% across 6+ discovery teams
- Designed data warehouse (dbt/S3) reducing compute cost by ~$75k/yr
- Built exec-ready dashboards guiding $10M+ R&D investment decisions
- Integrated predictive modeling into early-stage gates, improving progression precision by ~20%

---

## Previous Roles

**Chief Analytics Officer | ArchitectHealth | 2018-2019**

Directed analytics strategy for biotech portfolio companies, informing R&D investment decisions and improving client competitiveness through actionable insights.

**Data Scientist | Replica Analytics | 2019-2020**

Built privacy-preserving synthetic data pipelines for healthcare, enabling secure clinical data sharing while maintaining statistical validity.

---

## Education

**PhD | McMaster University | 2017-2022**

Developed multi-omics analysis pipelines and evaluation frameworks for translating complex biology into actionable decision contexts. Dissertation focused on designing decision systems under resource constraintsâ€”the foundation of my current approach to product decisions.

---

## Technical Capabilities

**Decision Systems Design**
- Evaluation frameworks (offline + online) that prevent metric theater
- North star + guardrails framework for product prioritization
- Stakeholder alignment forums with clear ownership

**Data Architecture & Engineering**
- dbt, SQL/Athena, S3/Parquet data warehouses
- Data contracts, lineage, and monitoring infrastructure
- Cost-optimized pipelines with reliability as first-class requirement

**Analytics & Visualization**
- R/Python, Shiny, Plotly, ggplot2, ECharts decision tools
- Statistical graphics and trade-off analyses for executives
- Interactive dashboards with clear decision CTAs

**Communication & Alignment**
- Executive storytelling through briefs, dashboards, and documentation
- Making tradeoffs explicit and decisions easy through clear framing
- Capturing institutional knowledge into durable, actionable findings

---

<div style="text-align: center; margin-top: 3rem; padding-top: 2rem; border-top: 1px solid var(--border-light);">
  <p><strong>Want to see how I think?</strong> Read my <a href="/case-studies/">full case studies</a> or explore my <a href="/consulting/">consulting services</a>.</p>
  <a href="/resume.pdf" download="Athan-Dial-Resume.pdf" style="display: inline-block; padding: 0.75rem 1.5rem; background-color: var(--accent); color: white; text-decoration: none; border-radius: 8px; font-weight: 500; transition: background-color 0.2s; margin-top: 1rem;">
    ðŸ“„ Download PDF Resume
  </a>
</div>
